Q-Wrapz: Oriel Morrison interviews Roby Zomer, Managing Director of MGC Pharma (ASX:MXC)
Link copied to
Stockhead’s Q-Wrapz video series features one-on-one interviews showcasing the latest quarterly results of emerging ASX companies.
In this instalment, former CNBC, Sky News, and Bloomberg news anchor Oriel Morrison interviews Roby Zomer, Co. Founder and Managing Director of MGC Pharmaceuticals Ltd (ASX:MXC).
MGC Pharma is a global biopharma company focused on developing and supplying high-quality phytotherapeutics and phytomedicines to patients in Europe, Australasia, and North America.
The company made headlines in July following news it would commence Phase III clinical trials on efficacy of its CimetrA drug in treating COVID-19 patients.
To learn more about the company’s quarterly highlights, standout areas and forward plan, click on the video above.